CYP2C19 and ABCB1 Genetic Polymorphisms Correlate With the Recurrence of Ischemic Cardiovascular Adverse Events After Clopidogrel Treatment

Journal of Clinical Laboratory Analysis - United States
doi 10.1002/jcla.22369

Related search